High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.7M
$1,670,870
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
AGIO
S
AGIOS PHARMACEUTICALS, INC.
Viswanadhan Krishnan
• Officer • Chief Corp Dev & Strategy
Sell to CoverΔOwn -36.5%
2026-03-05
$82,260
|
||||||
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Officer • Chief Corp Dev & Strategy
Sell to CoverΔOwn -36.5%
|
2026-03-05 | $82,260 | S | Form 4 |
|
AGIO
S
AGIOS PHARMACEUTICALS, INC.
Washburn Theodore James Jr.
• Officer • Principal Accounting Officer
Discretionary SellΔOwn -85.9%
2026-03-03
$152,255
|
||||||
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Officer • Principal Accounting Officer
Discretionary SellΔOwn -85.9%
|
2026-03-03 | $152,255 | S | Form 4 |
|
AGIO
S
AGIOS PHARMACEUTICALS, INC.
Milanova Tsveta
• Officer • Chief Commercial Officer
Sell to Cover
2026-03-02
$48,682
|
||||||
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Officer • Chief Commercial Officer
Sell to Cover
|
2026-03-02 | $48,682 | S | Form 4 |
|
AGIO
S
AGIOS PHARMACEUTICALS, INC.
Milanova Tsveta
• Officer • Chief Commercial Officer
Sell to Cover
2026-03-02
$34,376
|
||||||
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Officer • Chief Commercial Officer
Sell to Cover
|
2026-03-02 | $34,376 | S | Form 4 |
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-02 | $17,202 | S | Form 4 |
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-02 | $48,682 | S | Form 4 |
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-02 | $34,376 | S | Form 4 |
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-02 | $45,554 | S | Form 4 |
|
AGIO
S
AGIOS PHARMACEUTICALS, INC.
Gheuens Sarah
• Officer • Chief Medical Officer
Sell to Cover
2026-03-02
$34,376
|
||||||
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-03-02 | $34,376 | S | Form 4 |
|
AGIO
S
AGIOS PHARMACEUTICALS, INC.
Gheuens Sarah
• Officer • Chief Medical Officer
Sell to Cover
2026-03-02
$48,682
|
||||||
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-03-02 | $48,682 | S | Form 4 |
|
AGIO
S
AGIOS PHARMACEUTICALS, INC.
Burns James William
• Officer • Chief Legal Officer
Sell to Cover
2026-03-02
$34,376
|
||||||
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Officer • Chief Legal Officer
Sell to Cover
|
2026-03-02 | $34,376 | S | Form 4 |
|
AGIO
S
AGIOS PHARMACEUTICALS, INC.
Burns James William
• Officer • Chief Legal Officer
Sell to Cover
2026-03-02
$48,682
|
||||||
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Officer • Chief Legal Officer
Sell to Cover
|
2026-03-02 | $48,682 | S | Form 4 |
|
AGIO
S
AGIOS PHARMACEUTICALS, INC.
Burns James William
• Officer • Chief Legal Officer
Sell to Cover
2026-03-02
$33,680
|
||||||
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Officer • Chief Legal Officer
Sell to Cover
|
2026-03-02 | $33,680 | S | Form 4 |
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-02 | $112,075 | S | Form 4 |
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-02 | $239,412 | S | Form 4 |
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-02 | $171,385 | S | Form 4 |
|
AGIO
S
AGIOS PHARMACEUTICALS, INC.
Washburn Theodore James Jr.
• Officer • Principal Accounting Officer
Sell to CoverΔOwn -21.2%
2026-03-02
$20,214
|
||||||
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Officer • Principal Accounting Officer
Sell to CoverΔOwn -21.2%
|
2026-03-02 | $20,214 | S | Form 4 |
|
AGIO
S
AGIOS PHARMACEUTICALS, INC.
Washburn Theodore James Jr.
• Officer • Principal Accounting Officer
Sell to CoverΔOwn -14.6%
2026-03-02
$21,054
|
||||||
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Officer • Principal Accounting Officer
Sell to CoverΔOwn -14.6%
|
2026-03-02 | $21,054 | S | Form 4 |
|
AGIO
S
AGIOS PHARMACEUTICALS, INC.
Washburn Theodore James Jr.
• Officer • Principal Accounting Officer
Sell to CoverΔOwn -11.5%
2026-03-02
$23,110
|
||||||
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Officer • Principal Accounting Officer
Sell to CoverΔOwn -11.5%
|
2026-03-02 | $23,110 | S | Form 4 |
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-11-12 | $8,768 | S | Form 4 |
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Director
Other
|
2025-11-12 | $3,618 | M | Form 4 |
|
AGIO
S
AGIOS PHARMACEUTICALS, INC.
Gheuens Sarah
• Officer • Chief Medical Officer
10b5-1 Sell
2025-11-11
$107,436
|
||||||
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-11-11 | $107,436 | S | Form 4 |
|
AGIO
M
AGIOS PHARMACEUTICALS, INC.
Gheuens Sarah
• Officer • Chief Medical Officer
Other
2025-11-11
$61,375
|
||||||
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Officer • Chief Medical Officer
Other
|
2025-11-11 | $61,375 | M | Form 4 |
|
AGIO
M
AGIOS PHARMACEUTICALS, INC.
Gheuens Sarah
• Officer • Chief Medical Officer
Other
2025-10-30
$5,002
|
||||||
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Officer • Chief Medical Officer
Other
|
2025-10-30 | $5,002 | M | Form 4 |
|
AGIO
S
AGIOS PHARMACEUTICALS, INC.
Gheuens Sarah
• Officer • Chief Medical Officer
10b5-1 Sell
2025-10-30
$8,762
|
||||||
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-10-30 | $8,762 | S | Form 4 |
|
AGIO
S
AGIOS PHARMACEUTICALS, INC.
Gheuens Sarah
• Officer • Chief Medical Officer
10b5-1 Sell
2025-10-27
$145,024
|
||||||
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-10-27 | $145,024 | S | Form 4 |
|
AGIO
M
AGIOS PHARMACEUTICALS, INC.
Gheuens Sarah
• Officer • Chief Medical Officer
Other
2025-10-27
$82,583
|
||||||
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Officer • Chief Medical Officer
Other
|
2025-10-27 | $82,583 | M | Form 4 |
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-10-08 | $8,200 | S | Form 4 |
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Director
Other
|
2025-10-08 | $3,618 | M | Form 4 |
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Director
Other
|
2025-09-30 | $3,618 | M | Form 4 |
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-09-30 | $8,000 | S | Form 4 |
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2025-09-26 | $134,247 | S | Form 4 |